Response

Comment

Eric J Suba et al. J Natl Cancer Inst. 2013.

. 2013 Aug 21;105(16):1254-5.

doi: 10.1093/jnci/djt188. Epub 2013 Aug 1.

No abstract available

Comment on

RE: population-level impact of the bivalent, quadrivalent, and candidate nonavalent human papillomavirus vaccines: a comparative model-based analysis.
Suba EJ, González-Mena LE, Van Thái NE, Raab SS. Suba EJ, et al. J Natl Cancer Inst. 2013 May 1;105(9):664; discussion 665-6. doi: 10.1093/jnci/djt060. Epub 2013 Mar 15. J Natl Cancer Inst. 2013. PMID: 23503601 No abstract available.
RE: population-level impact of the bivalent, quadrivalent, and candidate nonavalent human papillomavirus vaccines: a comparative model-based analysis.
Castle P. Castle P. J Natl Cancer Inst. 2013 Aug 21;105(16):1254. doi: 10.1093/jnci/djt187. Epub 2013 Aug 1. J Natl Cancer Inst. 2013. PMID: 23907339 No abstract available.